Ketoconazole
Brand names: Ketoconazole, Ketodan
At a glance
- Medicare prescriptions, 2024
- 3,513,746
- Medicare drug cost
- $68.2M
- Average cost per prescription
- $19.40
- Clinicians who prescribed it
- 68,036
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
1. INDICATIONS AND USAGE Ketodan ® Foam, 2% is indicated for the topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older.
From the FDA-approved prescribing information (label dated December 2024). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Dermatology 33.1%
- Physician Assistants 18.9%
- Nurse Practitioners 12.5%
- Podiatrists 10.6%
- Family Medicine 10.4%
- Internal Medicine 9.2%
- General Practice 1.4%
- Mohs Surgery 1.3%
- Dermatopathology 0.6%
- Geriatric Medicine 0.5%
- Infectious Disease 0.2%
- Nephrology (Kidney) 0.1%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 55% from 2019 to 2024.
Biggest change by state since 2019
- New Hampshire +96%
- Utah +91%
- Colorado +83%
- Oklahoma +82%
- Connecticut +81%
- District of Columbia (smallest change) +27%
- Puerto Rico (smallest change) +28%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 2 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
A-S Medication Solutions
| Strength | Looks like | Imprint |
|---|---|---|
| 20 mg | white cream | |
Virbac Ah, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 23 mg / 10 mg ketoconazole | red shampoo | |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
Drug makers reported $581 in payments to clinicians that named this drug in 2025 (meals, speaking, consulting and similar).
- Medimetriks Pharmaceuticals, Inc. $581
Source: CMS Open Payments, general payments (not research), program year 2025. A payment is not evidence of wrongdoing. Payments by doctor
Recalls and shortages
Not on the FDA drug shortage list.
1 recall since 2020
- Apr 2022 · McKesson Medical-Surgical Inc. Corporate Office · Class II
cGMP deviations: Temperature abuse
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.